The CC-genotype of the cyclooxygenase-2 gene associates with decreased risk of nasopharyngeal carcinoma in a Tunisian population

Pathol Biol (Paris). 2015 Feb;63(1):7-10. doi: 10.1016/j.patbio.2014.10.008. Epub 2014 Nov 5.

Abstract

Background: The cyclooxygenase-2 (cox-2) pathway is now recognized to be important in human cancer development and progression. The gene for cox-2 carries a common single nucleotide polymorphism, T8473C, located within a potential functional region in the 3'-UTR of cox-2 gene was identified. We have investigated the frequencies of cox-2 genotypes in Tunisian population to determine whether that polymorphism was associated with the risk of nasopharyngeal carcinoma (NPC) in Tunisian population.

Material and methods: One hundred and eighty-nine NPC patients were compared to 237 healthy controls.

Results: The cox-2 T8473C polymorphism was significantly associated with NPC (P=0.031). The CC-genotype and C allele were more frequent in control compared to patients group [CC: OR=0.37; P=0.013; 95% CI: 0.17-0.81; C: OR=0.72; P=0.032; 95% CI: 0.53-0.97]. Multivariate logistic regression analyses revealed that the CC-genotype was associated with a significantly decreased risk of NPC (P=0.013). Tumor sizes, histologic grade, presence of primary lymph node metastases, age or sex were not associated with cox-2 genotypes.

Conclusion: We conclude that the CC-genotype and C allele of cox-2 T8473C gene polymorphism are associated with decreased risk of nasopharyngeal carcinoma in a Tunisian population.

Keywords: Association; Cancer du nasopharynx; Cox-2; Cyclooxygénase-2; Nasopharyngeal carcinoma; Polymorphisme T8473C; T8473C polymorphism.

MeSH terms

  • Adult
  • Aged
  • Carcinoma
  • Case-Control Studies
  • Cyclooxygenase 2 / genetics*
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / epidemiology
  • Nasopharyngeal Neoplasms / genetics*
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • Tunisia / epidemiology

Substances

  • Cyclooxygenase 2
  • PTGS2 protein, human